Comparison of In vivo [18F]Fluoro-desoxyglucose and [18F]Fluoro-thymidine Positron Emission Tomography for Disease Monitoring in a Mouse Model of Higher-Risk Myelodysplastic Syndrome
How to cite: Sarda-Mantel, L.; Gou, P.; Hontonnou, F.; Hosten, B.; Vignal, N.; San, C.; Brumpt, C.; Fenaux, P.; Chomienne, C.; Giraudier, S.; Padua, R. Comparison of In vivo [18F]Fluoro-desoxyglucose and [18F]Fluoro-thymidine Positron Emission Tomography for Disease Monitoring in a Mouse Model of Higher-Risk Myelodysplastic Syndrome. Preprints 2021, 2021040087. https://doi.org/10.20944/preprints202104.0087.v1 Sarda-Mantel, L.; Gou, P.; Hontonnou, F.; Hosten, B.; Vignal, N.; San, C.; Brumpt, C.; Fenaux, P.; Chomienne, C.; Giraudier, S.; Padua, R. Comparison of In vivo [18F]Fluoro-desoxyglucose and [18F]Fluoro-thymidine Positron Emission Tomography for Disease Monitoring in a Mouse Model of Higher-Risk Myelodysplastic Syndrome. Preprints 2021, 2021040087. https://doi.org/10.20944/preprints202104.0087.v1
Abstract
Keywords
Subject
Copyright: This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Comments (0)
We encourage comments and feedback from a broad range of readers. See criteria for comments and our Diversity statement.
Leave a public commentSend a private comment to the author(s)